{"DataElement":{"publicId":"7977005","version":"1","preferredName":"SARS Coronavirus 2 M Protein Mutation Abnormality Present Name","preferredDefinition":"Mutations observed in the spike protein that may cause infection leading to COVID-19.","longName":"SARS_COV_M_PRTN_AB_PSNT_NM","context":"NIH","contextVersion":"1","DataElementConcept":{"publicId":"7977001","version":"1","preferredName":"SARS Coronavirus 2 M Protein Mutation Abnormality Present","preferredDefinition":"A positive-sense single-stranded RNA virus in the genus Betacoronavirus. It is the causative agent of the 2019-2020 severe acute respiratory syndrome outbreak._A protein complex comprised of two heavy chains and two light chains. Monoclonal immunoglobulin (M protein) is found in abundance in patients who have multiple myeloma. The protein is not produced in response to an antigen, but it is expressed in malignant plasma cells and excreted into the blood and urine._Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer._Being or existing in a specified place or at the specified time.","longName":"7976999v1.0:2233878v1.0","context":"NIH","contextVersion":"1","ObjectClass":{"publicId":"7976999","version":"1","preferredName":"SARS Coronavirus 2 M Protein Mutation Abnormality","preferredDefinition":"A positive-sense single-stranded RNA virus in the genus Betacoronavirus. It is the causative agent of the 2019-2020 severe acute respiratory syndrome outbreak.:A protein complex comprised of two heavy chains and two light chains. Monoclonal immunoglobulin (M protein) is found in abundance in patients who have multiple myeloma. The protein is not produced in response to an antigen, but it is expressed in malignant plasma cells and excreted into the blood and urine.:Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","longName":"C169076:C17788:C45576","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2","conceptCode":"C169076","definition":"A positive-sense single-stranded RNA virus in the genus Betacoronavirus. It is the causative agent of the 2019-2020 severe acute respiratory syndrome outbreak.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"M Protein","conceptCode":"C17788","definition":"A protein complex comprised of two heavy chains and two light chains. Monoclonal immunoglobulin (M protein) is found in abundance in patients who have multiple myeloma. The protein is not produced in response to an antigen, but it is expressed in malignant plasma cells and excreted into the blood and urine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30B93BD-400F-311A-E053-4EBD850A57C5","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233878","version":"1","preferredName":"Present","preferredDefinition":"Being or existing in a specified place or at the specified time.","longName":"C25626","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Present","conceptCode":"C25626","definition":"Being or existing in a specified place or at the specified time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F970CDF6-F829-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30B93BD-401D-311A-E053-4EBD850A57C5","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"KUMMEROA","dateModified":"2022-02-16","changeDescription":"2022-2-16 ak Released per DW review. 2021-12-13 ak Created for Project 5 Tier 1.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7977003","version":"1","preferredName":"SARS Coronavirus 2 M Protein Mutation Abnormality Name","preferredDefinition":"A positive-sense single-stranded RNA virus in the genus Betacoronavirus. It is the causative agent of the 2019-2020 severe acute respiratory syndrome outbreak._A protein complex comprised of two heavy chains and two light chains. Monoclonal immunoglobulin (M protein) is found in abundance in patients who have multiple myeloma. The protein is not produced in response to an antigen, but it is expressed in malignant plasma cells and excreted into the blood and urine._Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer._The words or language units by which a thing is known.","longName":"SARS_COV_M_PRTN_AB_NM","context":"NIH","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"D614G","valueDescription":"SARS Coronavirus 2 Spike Glycoprotein D614G Substitution Positive","ValueMeaning":{"publicId":"7977004","version":"1","preferredName":"SARS Coronavirus 2 Spike Glycoprotein D614G Substitution Positive","longName":"7977004","preferredDefinition":"An indication that expression of SARS coronavirus 2 spike glycoprotein where the aspartic acid at amino acid position 614 has been substituted with glycine has been detected in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2 Spike Glycoprotein D614G Substitution Positive","conceptCode":"C179606","definition":"An indication that expression of SARS coronavirus 2 spike glycoprotein where the aspartic acid at amino acid position 614 has been substituted with glycine has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30BD2A9-92EB-3C6F-E053-4EBD850A4C88","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D30BD2A9-9304-3C6F-E053-4EBD850A4C88","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","deletedIndicator":"No"},{"value":"Other, Specify","valueDescription":"If Other, Specify","ValueMeaning":{"publicId":"7557010","version":"1","preferredName":"If Other, Specify","longName":"7557010","preferredDefinition":"A directive to specify when the listed responses are not sufficient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"If Other, Specify","conceptCode":"C157101","definition":"A directive to specify when the listed responses are not sufficient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9D26A12-EF66-4B33-E053-4EBD850ACC4C","latestVersionIndicator":"Yes","beginDate":"2021-01-26","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-01-26","modifiedBy":"CLOHNES","dateModified":"2022-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D30A5D87-A335-40CF-E053-4EBD850A352C","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","deletedIndicator":"No"},{"value":"69/70 Deletion","valueDescription":"SARS Coronavirus 2 Spike Glycoprotein 69/70 Deletion Positive","ValueMeaning":{"publicId":"7977011","version":"1","preferredName":"SARS Coronavirus 2 Spike Glycoprotein 69/70 Deletion Positive","longName":"7977011","preferredDefinition":"An indication that expression of SARS coronavirus 2 spike glycoprotein where the amino acids at positions 69 and 70 have been deleted has been detected in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2 Spike Glycoprotein 69/70 Deletion Positive","conceptCode":"C179614","definition":"An indication that expression of SARS coronavirus 2 spike glycoprotein where the amino acids at positions 69 and 70 have been deleted has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30A5D87-A342-40CF-E053-4EBD850A352C","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D30A5D87-A35B-40CF-E053-4EBD850A352C","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","deletedIndicator":"No"},{"value":"P681H","valueDescription":"SARS Coronavirus 2 Spike Glycoprotein P681H Substitution Positive","ValueMeaning":{"publicId":"7977012","version":"1","preferredName":"SARS Coronavirus 2 Spike Glycoprotein P681H Substitution Positive","longName":"7977012","preferredDefinition":"An indication that expression of SARS coronavirus 2 spike glycoprotein where the proline at amino acid position 681 has been substituted with histidine has been detected in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2 Spike Glycoprotein P681H Substitution Positive","conceptCode":"C179611","definition":"An indication that expression of SARS coronavirus 2 spike glycoprotein where the proline at amino acid position 681 has been substituted with histidine has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30A5D87-A367-40CF-E053-4EBD850A352C","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D30A5D87-A380-40CF-E053-4EBD850A352C","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","deletedIndicator":"No"},{"value":"E484K","valueDescription":"SARS Coronavirus 2 Spike Glycoprotein E484K Substitution Positive","ValueMeaning":{"publicId":"7977013","version":"1","preferredName":"SARS Coronavirus 2 Spike Glycoprotein E484K Substitution Positive","longName":"7977013","preferredDefinition":"An indication that expression of SARS coronavirus 2 spike glycoprotein where the glutamic acid at amino acid position 484 has been substituted with lysine has been detected in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2 Spike Glycoprotein E484K Substitution Positive","conceptCode":"C179610","definition":"An indication that expression of SARS coronavirus 2 spike glycoprotein where the glutamic acid at amino acid position 484 has been substituted with lysine has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30A5D87-A38C-40CF-E053-4EBD850A352C","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D30A5D87-A3A5-40CF-E053-4EBD850A352C","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","deletedIndicator":"No"},{"value":"K417N/T","valueDescription":"SARS Coronavirus 2 Spike Glycoprotein K417N/T Substitution Positive","ValueMeaning":{"publicId":"7977014","version":"1","preferredName":"SARS Coronavirus 2 Spike Glycoprotein K417N/T Substitution Positive","longName":"7977014","preferredDefinition":"An indication that expression of SARS coronavirus 2 spike glycoprotein where the lysine at amino acid position 417 has been substituted with either asparagine or threonine has been detected in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2 Spike Glycoprotein K417N/T Substitution Positive","conceptCode":"C179609","definition":"An indication that expression of SARS coronavirus 2 spike glycoprotein where the lysine at amino acid position 417 has been substituted with either asparagine or threonine has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30A5D87-A3B1-40CF-E053-4EBD850A352C","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D30A5D87-A3CA-40CF-E053-4EBD850A352C","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","deletedIndicator":"No"},{"value":"N501Y","valueDescription":"SARS Coronavirus 2 Spike Glycoprotein N501Y Substitution Positive","ValueMeaning":{"publicId":"7977015","version":"1","preferredName":"SARS Coronavirus 2 Spike Glycoprotein N501Y Substitution Positive","longName":"7977015","preferredDefinition":"An indication that expression of SARS coronavirus 2 spike glycoprotein where the asparagine at amino acid position 501 has been substituted with tyrosine has been detected in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2 Spike Glycoprotein N501Y Substitution Positive","conceptCode":"C179608","definition":"An indication that expression of SARS coronavirus 2 spike glycoprotein where the asparagine at amino acid position 501 has been substituted with tyrosine has been detected in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30A5D87-A3D6-40CF-E053-4EBD850A352C","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D30A5D87-A3EF-40CF-E053-4EBD850A352C","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7977008","version":"1","preferredName":"SARS Coronavirus 2 M Protein Mutation Abnormality Name","preferredDefinition":"A positive-sense single-stranded RNA virus in the genus Betacoronavirus. It is the causative agent of the 2019-2020 severe acute respiratory syndrome outbreak.:A protein complex comprised of two heavy chains and two light chains. Monoclonal immunoglobulin (M protein) is found in abundance in patients who have multiple myeloma. The protein is not produced in response to an antigen, but it is expressed in malignant plasma cells and excreted into the blood and urine.:Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.:The words or language units by which a thing is known.","longName":"C169076:C17788:C45576:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SARS Coronavirus 2","conceptCode":"C169076","definition":"A positive-sense single-stranded RNA virus in the genus Betacoronavirus. It is the causative agent of the 2019-2020 severe acute respiratory syndrome outbreak.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"M Protein","conceptCode":"C17788","definition":"A protein complex comprised of two heavy chains and two light chains. Monoclonal immunoglobulin (M protein) is found in abundance in patients who have multiple myeloma. The protein is not produced in response to an antigen, but it is expressed in malignant plasma cells and excreted into the blood and urine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Mutation Abnormality","conceptCode":"C45576","definition":"Any transmissible change in the genetic material of an organism, which can result from radiation, viral infection, transposition, treatment with mutagenic chemicals and errors during DNA replication or meiosis. The effects of mutation range from single base changes to loss or gain of complete chromosomes. As many of the simpler alterations to DNA may be repaired, such changes are only heritable once the change is fixed in the DNA by the process of replication. Mutations may be associated with genetic diversity or with pathologies including cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30C0683-EAE1-342B-E053-4EBD850AD913","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"ONEDATA","dateModified":"2021-12-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D30BD2A9-92D4-3C6F-E053-4EBD850A4C88","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"KUMMEROA","dateModified":"2022-02-16","changeDescription":"2022-2-16 ak Released per DW. 2021-12-13 ak Created for Project 5 Tier 1.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"7244861","version":"1","longName":"COVID-19","context":"NCIP","ClassificationSchemeItems":[{"publicId":"8038915","version":"1","longName":"NIH","context":"NCIP"},{"publicId":"8038916","version":"1","longName":"Project 5 CDEs","context":"NCIP"}]},{"publicId":"7977821","version":"1","longName":"Project 5 COVID","context":"NIH","ClassificationSchemeItems":[{"publicId":"7977823","version":"1","longName":"Tier 1","context":"NIH"}]}],"AlternateNames":[{"name":"SARS-CoV-2 Spike Protein Mutations Name","type":"NIH COVID","context":"NIH"}],"ReferenceDocuments":[{"name":"What spike protein mutations","type":"Preferred Question Text","description":"What spike protein mutations were noted?","url":null,"context":"NIH"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D307A44C-CC2D-4DDC-E053-4EBD850A41BC","latestVersionIndicator":"Yes","beginDate":"2021-12-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-12-13","modifiedBy":"KUMMEROA","dateModified":"2022-02-16","changeDescription":"2022-2-16 ak Released per DW review. 2021-12-13 ak Created for Project 5 Tier 1.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}